Ligand validation:6GAX

AMP: ADENOSINE MONOPHOSPHATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GAX_AMP_A_501	95%	44%	0.079	0.984	0.81	1.32	-	2	0	0	100%	1
6GBF_AMP_A_501	98%	46%	0.065	0.988	0.91	1.16	1	2	0	0	100%	1
6GBC_AMP_A_501	97%	41%	0.072	0.986	1.01	1.27	1	3	0	0	100%	1
6ETD_AMP_A_501	97%	45%	0.069	0.982	0.93	1.18	1	2	0	0	100%	1
6GB4_AMP_A_501	97%	39%	0.069	0.982	0.95	1.41	2	4	0	0	100%	1
6GB9_AMP_A_501	97%	43%	0.072	0.985	0.95	1.24	2	2	0	0	100%	1
8YNQ_AMP_D_504	100%	43%	0.041	0.99	0.96	1.26	1	2	11	0	100%	1
3G89_AMP_B_304	100%	32%	0.038	0.986	1.05	1.63	1	4	6	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.78
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.